ACME Laboratories

DSE: ACMELAB

Pharmaceuticals · ACME Group

ACME Laboratories is a long-established Bangladeshi pharmaceutical manufacturer and the flagship of the diversified ACME Group. It develops, manufactures, and markets human and veterinary medicines for the domestic market and exports.

Business: Generic and branded prescription and over-the-counter human pharmaceuticals across major therapeutic classes, plus animal health products, herbal and consumer health lines. Operations include large-scale formulation manufacturing and a domestic distribution network.

Market data

Market capitalisation

16,230 mn BDT

Paid-up capital

2,116 mn BDT

Outstanding shares

211,601,700

Last price

76.5 BDT

Listed

2016

Market category

A

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Industry concentration in domestic pharma manufacturing A handful of large local firms including ACME dominate domestic drug supply, so their pricing and quality practices materially shape public access to medicines and out-of-pocket health spending. Source: analysis

Group conglomerate structure and related-party governance As the flagship of a diversified family group, intra-group transactions and governance disclosure quality are a standing concern for minority investors and the securities regulator. Source: analysis

Quality regulation and export market compliance Domestic GMP enforcement by the Directorate General of Drug Administration and compliance with importing-country standards determine whether local manufacturers like ACME can expand exports and retain consumer trust. Source: Directorate General of Drug Administration (DGDA)